Neo-adjuvant chemotherapy followed by surgery versus surgery alone in high-risk patients with resectable colorectal liver metastases: the CHARISMA randomized multicenter clinical trial

N. Ayez; E.P. van der Stok; H. de Wilt; S.A. Radema; R. van Hillegersberg; R.M. Roumen; G. Vreugdenhil; P.J. Tanis; C.J. Punt; C.H. Dejong; R.L. Jansen; H.M. Verheul; K.P. de Jong; G.A. Hospers; J.M. Klaase; M.C. Legdeur; E. van Meerten; F.A. Eskens; N. van der Meer; B. van der Holt; C. Verhoef; D.J. Grunhagen

doi:10.1186/s12885-015-1199-8

Neo-adjuvant chemotherapy followed by surgery versus surgery alone in high-risk patients with resectable colorectal liver metastases: the CHARISMA randomized multicenter clinical trial

N. Ayez, E.P. van der Stok, H. de Wilt, S.A. Radema, R. van Hillegersberg, R.M. Roumen, G. Vreugdenhil, P.J. Tanis, C.J. Punt, C.H. Dejong, R.L. Jansen, H.M. Verheul, K.P. de Jong, G.A. Hospers, J.M. Klaase, M.C. Legdeur, E. van Meerten, F.A. Eskens, N. van der Meer, B. van der HoltC. Verhoef, D.J. Grunhagen

Medical oncology

Research output: Contribution to journal › Article › Academic › peer-review

Original language	Undefined/Unknown
Article number	180
Journal	BMC Cancer
Volume	15
DOIs	https://doi.org/10.1186/s12885-015-1199-8
Publication status	Published - 2015

Access to Document

10.1186/s12885-015-1199-8

Cite this

Ayez, N., van der Stok, E. P., de Wilt, H., Radema, S. A., van Hillegersberg, R., Roumen, R. M., Vreugdenhil, G., Tanis, P. J., Punt, C. J., Dejong, C. H., Jansen, R. L., Verheul, H. M., de Jong, K. P., Hospers, G. A., Klaase, J. M., Legdeur, M. C., van Meerten, E., Eskens, F. A., van der Meer, N., ... Grunhagen, D. J. (2015). Neo-adjuvant chemotherapy followed by surgery versus surgery alone in high-risk patients with resectable colorectal liver metastases: the CHARISMA randomized multicenter clinical trial. BMC Cancer, 15, [180]. https://doi.org/10.1186/s12885-015-1199-8

@article{158f946483644fee96b0e4acf66a9037,

title = "Neo-adjuvant chemotherapy followed by surgery versus surgery alone in high-risk patients with resectable colorectal liver metastases: the CHARISMA randomized multicenter clinical trial",

author = "N. Ayez and {van der Stok}, E.P. and {de Wilt}, H. and S.A. Radema and {van Hillegersberg}, R. and R.M. Roumen and G. Vreugdenhil and P.J. Tanis and C.J. Punt and C.H. Dejong and R.L. Jansen and H.M. Verheul and {de Jong}, K.P. and G.A. Hospers and J.M. Klaase and M.C. Legdeur and {van Meerten}, E. and F.A. Eskens and {van der Meer}, N. and {van der Holt}, B. and C. Verhoef and D.J. Grunhagen",

year = "2015",

doi = "10.1186/s12885-015-1199-8",

language = "Undefined/Unknown",

volume = "15",

journal = "BMC Cancer",

issn = "1471-2407",

publisher = "BioMed Central",

}

Ayez, N, van der Stok, EP, de Wilt, H, Radema, SA, van Hillegersberg, R, Roumen, RM, Vreugdenhil, G, Tanis, PJ, Punt, CJ, Dejong, CH, Jansen, RL, Verheul, HM, de Jong, KP, Hospers, GA, Klaase, JM, Legdeur, MC, van Meerten, E, Eskens, FA, van der Meer, N, van der Holt, B, Verhoef, C & Grunhagen, DJ 2015, 'Neo-adjuvant chemotherapy followed by surgery versus surgery alone in high-risk patients with resectable colorectal liver metastases: the CHARISMA randomized multicenter clinical trial', BMC Cancer, vol. 15, 180. https://doi.org/10.1186/s12885-015-1199-8

TY - JOUR

T1 - Neo-adjuvant chemotherapy followed by surgery versus surgery alone in high-risk patients with resectable colorectal liver metastases: the CHARISMA randomized multicenter clinical trial

AU - Ayez, N.

AU - van der Stok, E.P.

AU - de Wilt, H.

AU - Radema, S.A.

AU - van Hillegersberg, R.

AU - Roumen, R.M.

AU - Vreugdenhil, G.

AU - Tanis, P.J.

AU - Punt, C.J.

AU - Dejong, C.H.

AU - Jansen, R.L.

AU - Verheul, H.M.

AU - de Jong, K.P.

AU - Hospers, G.A.

AU - Klaase, J.M.

AU - Legdeur, M.C.

AU - van Meerten, E.

AU - Eskens, F.A.

AU - van der Meer, N.

AU - van der Holt, B.

AU - Verhoef, C.

AU - Grunhagen, D.J.

PY - 2015

Y1 - 2015

U2 - 10.1186/s12885-015-1199-8

DO - 10.1186/s12885-015-1199-8

M3 - Article

C2 - 25884448

VL - 15

JO - BMC Cancer

JF - BMC Cancer

SN - 1471-2407

M1 - 180

ER -